Skip to content
OpenCapital
Get started

Vivani Medical VANI Q2 2025 earnings

Reported August 13, 2025 · Before market open

Revenue-Diluted EPS-$0.12Miss by $0.02
EPS estimate-$0.10

Next report

Aug 12, 2026 (In 3 weeks)
EPS estimate-$0.08

Financials

Q2 2025

Income statement

See full
Revenue-—
Operating income-$7.5M-31.4%
Net income-$7.1M-33.4%
EPS (diluted)-$0.12-20.0%

Balance sheet

See full
Cash & equivalents$5.8M-75.7%
Total debt$18.6M-7.7%
Total equity$4.9M-79.4%
Total assets$28.9M-40.1%

Cash flow

See full
Operating cash flow-$6.1M-26.8%
CapEx$71.0K+91.9%
Free cash flow-$6.2M-27.3%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$75.24M+8.6%
Enterprise value$88.04M+34.3%

Returns & leverage

See full
Return on equity-177.7%-2,941pp
Debt / equity3.8×+2.9×
Current ratio1.3×-3.3×

Versus estimates

Revenue

Q4 2024$398.0K

Diluted EPS

Q1 2026-$0.08In lineQ4 2025-$0.09In lineQ3 2025-$0.11Beat by $0.01
Q2 2025-$0.12Miss by $0.02
Q1 2025-$0.11Miss by $0.01Q4 2024-$0.11Miss by $0.01

Ask the moment Vivani Medical reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Vivani Medical report Q2 2025 earnings?
Vivani Medical (VANI) reported Q2 2025 earnings on August 13, 2025 before market open.
What were Vivani Medical's Q2 2025 revenue and EPS?
Vivani Medical reported revenue of - and diluted EPS of $-0.12 for Q2 2025.
Did Vivani Medical beat estimates in Q2 2025?
EPS missed the consensus estimate of $-0.10 by $0.02.
How did Vivani Medical's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS declined 20.0% from $-0.10.
Where can I find Vivani Medical's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001753926-25-001330) directly on SEC EDGAR. The filing index links above go to sec.gov.